CM Hospitalar S/A

VVEO3

BRVVEOACNOR0

Pharmaceuticals

Market Closed - Sao Paulo Other stock markets 04:06:00 2024-04-24 pm EDT			5-day change	1st Jan Change
5.83 ^BRL	-10.99%		-12.72%	-58.21%

Mar. 26	CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 26	CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.

May 10, 2022

CM Hospitalar S/A (BOVESPA:VVEO3) entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others on May 11, 2022. As part of the transaction, Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. will divest all its stake in Pro-Formula Quimioterapica Ltda.

Latest news about CM Hospitalar S/A

CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 25	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index	Dec. 29	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-09	CI
CM Hospitalar S/A acquired remaining stake in Far.me.	23-02-05	CI
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.	22-08-23	CI
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-09	CI
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions	22-06-08	RE
CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.	22-05-10	CI
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-09	CI
CM Hospitalar S/A acquired Boxifarma.	22-04-18	CI
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-10	CI
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-03-10	CI
CM Hospitalar S/A(BOVESPA:VVEO3) added to S&P Global BMI Index	21-12-20	CI
CM Hospitalar S/A acquired Macromed Produtos Hospitalares Ltda.	21-11-15	CI
CM Hospitalar S/A entered into Purchase and Sale agreement to acquire Laborsys Produtos Produtos e Hospitalares Ltda.	21-11-11	CI
CM Hospitalar S/A has completed an IPO in the amount of BRL 1.87698 billion.	21-08-06	CI
CM Hospitalar S/A has filed an IPO.	21-02-03	CI

Chart CM Hospitalar S/A

Duration

Period

More charts

Company Profile

CM Hospitalar SA, formerly known as a CM Hospitalar Ltda, is a Brazil-based public company which engages in the wholesale trade of medicines, drugs, and hospital supplies. The Company operates mainly in export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade in general, acting mainly in the trade in health products, as a middleman between industries and hospitals, clinics, home cares and health institutions in the private and public market, in addition to participating in other investments. It operates throughout Brazil with a commercial and logistical structure. The Company's medium and long-term planning encompasses the acquisition of companies from the segment and an important commercial strengthening throughout Brazil, expanding its position in the distribution of medicines and hospital supplies.

Sector

Pharmaceuticals

Calendar

2024-04-29 - Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for CM Hospitalar S/A

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.83 BRL

Average target price

17.84 BRL

Spread / Average Target

+206.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CM HOSPITALAR S/A	-58.21%	362M
MCKESSON CORPORATION	+15.65%	70.36B
CARDINAL HEALTH, INC.	+2.72%	25.18B
SINOPHARM GROUP CO. LTD.	+5.62%	8.61B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+6.10%	8.14B
HUADONG MEDICINE CO., LTD	-21.85%	7.83B
H. LUNDBECK A/S	+0.73%	4.56B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.40%	4.32B
EBOS GROUP LIMITED	-0.14%	4.06B
GALENICA AG	-2.34%	3.87B

Pharmaceuticals Wholesale

CM Hospitalar S/A

Equities

VVEO3

BRVVEOACNOR0

Pharmaceuticals

CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.

EPS Revisions